May 4, 2020
Teva, Celltrion Healthcare launch Truxima in US for Rheumatoid Arthritis, Rituxan biosimilar
Truxima, the only US biosimilar to Rituxan, is also now available for the treatment of Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA).